Despite these hurdles, there is a growing acceptance of glucagon like peptide 1 analogs in India, and with increasing generic availability and improved healthcare infrastructure, their use is expected to expand, making them more accessible to a larger patient population
Biomed Pharmacother 2018;108:952-62.ArticlePubMed 14
As with all insulins, the glucose lowering effect time course of Tresiba Risk Factors for Hypoglycemia: may vary among different patients or at different times in the same patients and depends on many conditions, including the area of injection as well as the injection site blood supply and temperature
The EMA recommended adding NAION to the product information (similar to the drugs warning label)
AT-7687, a novel GIPR peptide antagonist, combined with a GLP-1 agonist, leads to enhanced weight loss and metabolic improvements in cynomolgus monkeys
Cancer risk from alcohol is not binary (safe / not safe) but proportional more alcohol generally means higher incremental risk